Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

Ozempic may be used off-label for weight loss. However, some people may experience weight gain while using Ozempic or after ...

High School Musical alum Ashley Tisdale detailed her decision not to use Ozempic to assist with weight loss after giving ...